Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Why should I use sharewise

Created by stratec 

Amarin Corp. ADR diskutieren

Published 26.01.20
Prediction Buy
Perf. (%) -66.487%
Target price 30.000
Change

Buy mit Kursziel 30,0

Published 28.01.20
Prediction Buy
Perf. (%) 5.294%
Target price 30.000
Change

Buy beendet

Published 28.01.20
Prediction Buy
Perf. (%) -11.413%
Target price 35.000
Change

Buy mit Kursziel 35,0

Published 08.02.20
Prediction Buy
Perf. (%) 2.454%
Target price 30.000
Change

Buy mit Kursziel 30,0

Published 14.02.20
Prediction Buy
Perf. (%) -1.212%
Target price 30.000
Change

Buy mit Kursziel 30,0

Published 23.02.20
Prediction Buy
Perf. (%) -20.958%
Target price 28.000
Change

Buy mit Kursziel 28,0

Published 25.02.20
Prediction Buy
Perf. (%) -34.356%
Target price 27.000
Change

Buy mit Kursziel 27,0

Published 08.03.20
Prediction Buy
Perf. (%) -12.195%
Target price 23.000
Change

Buy mit Kursziel 23,0

Published 20.03.20
Prediction Buy
Perf. (%) -41.346%
Target price 20.000
Change

Buy mit Kursziel 20,0

Published 21.03.20
Prediction Buy
Perf. (%) -55.282%
Target price 20.000
Change

Buy mit Kursziel 20,0

Buy Amarin Corp. ADR

Published 31.03.20
Prediction Buy
Perf. (%) 15.344%
Target price 4.000
Change

Buy mit Kursziel 4,0

@Vassago1  schrieb
Nachdem ein US-Bezirksgericht wichtige Patente für Vascepa für ungültig erklärt hat und die Aktie an einem Tag knapp 70% an Wert eingebüßt hat, spekuliere ich nun mit 2K im Musterdepot darauf, dass die Berufung für Amarin positiv ausgehen wird. Die erste Position war mit 2% gewichtet und wurde bei 14$ eingegangen. 

Amarin (AMRN +25.0%) is up on massive turnover of over 63M shares in apparent reaction to a call between a patent lawyer and Jefferies' Jared Holtz about the adverse patent ruling on Vascepa (icosapent ethyl) that caused the stock to plummet almost 71% yesterday. The attorney said the company has an even-money chance to win on appeal citing a possible procedural error in the case.


Published 04.04.20
Prediction Buy
Perf. (%) 35.371%
Target price 8.000
Change

Buy mit Kursziel 8,0

Published 30.04.20
Prediction Buy
Perf. (%) -21.519%
Target price 12.000
Change

Buy mit Kursziel 12,0

Buy Amarin Corp. ADR

Published 22.05.20
Prediction Sell
Perf. (%) 13.223%
Target price
Change

Sell Amarin Corp. ADR

Published 25.05.20
Prediction Buy
Perf. (%) -9.489%
Target price
Change

Buy Amarin Corp. ADR

You are not allowed to take part in this discussion. If you have any questions please contact the thread starter.
{:page=>4, :per=>20, :last=>"true", :count=>78}